Clinical Profile of Gilteritinib in Japanese Patients with Relapsed/Refractory AML: an Open ‐Label Phase 1 Study

Cancer Science,Volume 0, Issue ja, -Not available-.

Source: Cancer Science - July 24, 2018 Category: Cancer & Oncology Authors: Kensuke Usuki , Toru Sakura , Yukio Kobayashi , Toshihiro Miyamoto , Hiroatsu Iida , Satoshi Morita , Erkut Bahceci , Masahito Kaneko , Mikiko Kusano , Shunsuke Yamada , Shigeru Takeshita , Shuichi Miyawaki , Tomoki Naoe Source Type: research